Invested in Facebook, SpaceX and many cattle companies, how does the most prolific VC in the US work in the digital health field?
Recently, Rockhealth, a well-known medical and health venture capital institution in the United States, announced the “Top 50 Digital Health†list. The annual fixed program attracted many people’s attention. Among them, venture capital firm Founders Fund listed "the most prolific VC", becoming the most concerned investment institution in the digital health field.
Although it was first debuted in the field of medical and health ventures, the Founders Fund has a proven track record. Its managing partner is the “Paypal Gangâ€, which has invested in companies such as Facebook, SpaceX and Airbnb. The Arterial Network took stock of the Founders Fund's layout in the health care field and explained its mystery.
As a well-known investment institution, Founders Fund Ventures is committed to supporting Web 2.0 companies. It provided the Facebook founder with $500,000 in startup funding in 2004, and the investment earned 20,000 times.
The Founders Fund is involved in a variety of investments, including Airbnb, SpaceX and Palantir Technologies. The main contents of this paper include:
Founders Fund's medical map: involved in multiple segments, with a maximum investment of hundreds of millions;
History of Founders Fund: A number of star investors help.
Founders Fund's medical map: involved in multiple segments, the largest single investment billion
The following are the main investments of the Founders Fund in the medical field:
(Source: crunchbase)
Oscar Health
In March 2018, Oscar Health announced that it had completed $165 million in financing, with major investors being Brian Singerman and Founders Fund. In January 2014 and April 2015, Founders Fund also participated in the A-round and C-round financing of Oscar Health as a major investor, with financing amounts of $30 million and $145 million, respectively.
Founded in 2013, Oscar Health focuses on technology, design and data to improve healthcare. At present, Oscar Health has established a relatively complete business model, which is to create a new medical system to ensure competitive prices, attract a large number of members and increase their activity, help cooperative suppliers to develop markets, and reduce medical costs. . Therefore, Oscar plans to use the latest financing to accelerate product development and improve the quality of medical services.
Stemcentrx
In 2012, cancer drug developer Stemcentrx completed a $42 million Series D financing, and Founders Fund, a major investor, contributed $30 million. Since then, Founders Fund has become Stemcentrx's largest external shareholder with a total investment of approximately $300 million, making it the largest single investment by Founders Fund, with investment exceeding the investment in SpaceX.
At the end of 2014, Stemcentrx became a unicorn company in the field of cancer drug discovery. In 2016, pharmaceutical giant AbbVie acquired Stemcentrx, a cancer drug developer for $10.2 billion, with a transaction volume of $10.2 billion. It is one of the largest acquisitions in biotechnology in recent years.
Collective Health
Collective Health provides more choices for self-insurance companies through a cloud-based health benefits integration platform, while helping them get more out of their healthcare investments. Collective Health partners include Activision Blizzard, Crossfit, eBay, Palantir and Red Bull.
In January 2014, Collective Health completed a $6 million Series A financing, which was led by Founders Fund. In February 2018, Collective Health completed a $110 million Series D financing, bringing its total financing amount to $229 million.
Ritual
Founded in 2015, Ritual is the first product to be a non-GMO, sugar-free daily vitamin designed to help women replenish nutrition, improve mood and fight aging.
In August 2017, Ritual completed a $10.5 million Series A round of financing, led by Founders Fund, and other investors include Forerunner Ventures, Northwest Ventures Norwest Venture Partners and Front Ventures. Ritual founder Katerina Markov Schneider said that the choice of Founders Fund as the leader of this round of financing is based on the company's "want to change the world's philosophy, solutions to complex problems and firm beliefs." Ritual plans to use this financing to attract talent and expand its business.
Forward
Forward is a start-up company, established in January 2016, to redefine medical devices with algorithm-supported diagnostic tools and genetic, bacterial and blood tests using technologies such as sensors, mobile devices and artificial intelligence in conjunction with medical trends. medical insurance.
Forward's core product is a special body scanner that collects vital signs such as body temperature and pulse and sends this information to the patient or doctor. In 2016, Forward completed two rounds of financing, including the Founders Fund and some well-known investors and entrepreneurs in Silicon Valley.
UNITY Biotechnology
Biotechnology company UNITY Biotechnology was founded in 2009 to work on anti-aging research. Its research and development focus is on an anti-aging drug that selectively removes aging cells to treat age-related diseases such as osteoarthritis, eye diseases and lung diseases.
In March 2018, UNITY Biotechnology completed a $55 million Series C financing, including EcoR1 Capital Fund, 6 Dimensions Capital, Altitude Life Science Ventures and Founders Fund, which will be used for clinical trials of drug candidates and the first Application for experimental new drugs.
Emerald Therapeutics
Emerald Therapeutics is a biotechnology company that aims to redefine how laboratory research works. In 2014, Emerald Therapeutics completed a $6 million Series B round of financing, including Founders Fund, PayPal co-founder Max Levchin and Schooner Capital. At the same time, the company also launched its first product, the Emerald Cloud Lab (ECL), which allows scientists to access it remotely via the Internet, and automated robots experiment in a way that users specify.
In addition, in 2015, Founders Fund also participated in the E-round financing of Emerald Therapeutics, with a financing amount of US$20.5 million. Other participants include OS Fund and Sound Ventures.
Cosmetics Products,Cosmeticghk-Cu Raw Powder,Copper Peptide,Ghk-Cu Powder Cosmetics
Shaanxi Hongbaiyi Biotech Co., Ltd. , https://www.sxhongbaiyi.com